According to media reports, the regulator has communicated through the Indian Drug Manufacturers' Association (IDMA) to identify companies that can immediately supply ifosfamide injection, a generic chemotherapy drug used in the treatment of several cancers, including testicular, bladder and lung cancer.
The US is currently experiencing a shortage of ifosfamide injection, a generic chemotherapy drug essential for treating various cancers. In response, the US regulator has contacted the Indian Drug Manufacturers' Association (IDMA) to identify Indian pharmaceutical companies…
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.